EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
35 hedge funds and large institutions have $139M invested in ESSA Pharma in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+15
Holders Change %
+75%
% of All Funds
0.71%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
11
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$14.4M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$10.5M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$7.04M |
| 4 |
SCM
Sio Capital Management
New York
|
+$4.53M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.78M |
Top Sellers
| 1 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$3.91M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$2.61M |
| 3 |
O
OrbiMed
New York
|
-$2.03M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.76M |
